Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-13

Clinical Trial Update: Low Field Magnetic Stimulation: Open Label Study. [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial evaluating the use of Low Field Magnetic Stimulation for mood disorders and anxiety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low Field Magnetic Stimulation (LFMS)

Snippet

Sponsor: Mclean Hospital | Conditions: Mood Disorders, Anxiety | Phase 1, Phase 2 | Status: UNKNOWN